231 related articles for article (PubMed ID: 34301919)
1. RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.
Meng Y; Zhang Q; Wang K; Zhang X; Yang R; Bi K; Chen W; Diao H
Cell Death Dis; 2021 Jul; 12(8):732. PubMed ID: 34301919
[TBL] [Abstract][Full Text] [Related]
2. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent.
Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y
J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103
[TBL] [Abstract][Full Text] [Related]
3. RBM15 suppresses hepatic insulin sensitivity of offspring of gestational diabetes mellitus mice via m6A-mediated regulation of CLDN4.
Fang J; Wu X; He J; Zhang H; Chen X; Zhang H; Novakovic B; Qi H; Yu X
Mol Med; 2023 Feb; 29(1):23. PubMed ID: 36803098
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of N6-methyladenosine RBM15 regulators in lung adenocarcinoma.
Ma M; Wang W; Wang B; Yang Y; Huang Y; Zhao G; Ye L
Cell Mol Biol (Noisy-le-grand); 2022 May; 68(1):130-139. PubMed ID: 35809319
[TBL] [Abstract][Full Text] [Related]
5. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.
Li N; Hui H; Bray B; Gonzalez GM; Zeller M; Anderson KG; Knight R; Smith D; Wang Y; Carlin AF; Rana TM
Cell Rep; 2021 May; 35(6):109091. PubMed ID: 33961823
[TBL] [Abstract][Full Text] [Related]
6. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3.
Lan T; Li H; Zhang D; Xu L; Liu H; Hao X; Yan X; Liao H; Chen X; Xie K; Li J; Liao M; Huang J; Yuan K; Zeng Y; Wu H
Mol Cancer; 2019 Dec; 18(1):186. PubMed ID: 31856849
[TBL] [Abstract][Full Text] [Related]
7. RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.
Wang R; Tan W
Crit Rev Eukaryot Gene Expr; 2024; 34(5):15-29. PubMed ID: 38842201
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
[TBL] [Abstract][Full Text] [Related]
9. Knockdown RBM15 Inhibits Colorectal Cancer Cell Proliferation and Metastasis Via N6-Methyladenosine (m6A) Modification of MyD88 mRNA.
Zhang Z; Mei Y; Hou M
Cancer Biother Radiopharm; 2022 Dec; 37(10):976-986. PubMed ID: 34842457
[TBL] [Abstract][Full Text] [Related]
10. RBM15-Mediated m6A Modification of K17 Affects Keratinocytes Response to IL-17A Stimulation in Psoriasis.
Fu M; Zhou B; Shi N; Dong R; Chen Y
Ann Clin Lab Sci; 2023 Jul; 53(4):529-538. PubMed ID: 37625827
[TBL] [Abstract][Full Text] [Related]
11. Cracking the epitranscriptome.
Schwartz S
RNA; 2016 Feb; 22(2):169-74. PubMed ID: 26787305
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine modification and the YTHDF2 reader protein play cell type specific roles in lytic viral gene expression during Kaposi's sarcoma-associated herpesvirus infection.
Hesser CR; Karijolich J; Dominissini D; He C; Glaunsinger BA
PLoS Pathog; 2018 Apr; 14(4):e1006995. PubMed ID: 29659627
[TBL] [Abstract][Full Text] [Related]
13. The role of the Xist 5' m6A region and RBM15 in X chromosome inactivation.
Coker H; Wei G; Moindrot B; Mohammed S; Nesterova T; Brockdorff N
Wellcome Open Res; 2020; 5():31. PubMed ID: 32258426
[No Abstract] [Full Text] [Related]
14. Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.
Zeng X; Chen K; Li L; Tian J; Ruan W; Hu Z; Peng D; Chen Z
Free Radic Biol Med; 2022 May; 184():135-147. PubMed ID: 35381326
[TBL] [Abstract][Full Text] [Related]
15. Detection of N6-methyladenosine in SARS-CoV-2 RNA by methylated RNA immunoprecipitation sequencing.
Li N; Rana TM
STAR Protoc; 2022 Mar; 3(1):101067. PubMed ID: 34901888
[No Abstract] [Full Text] [Related]
16. RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.
Ma M; Wang W; Li L; Wang X; Huang Q; Zhou C; Huang Y; Zhao G; Ye L
Transl Oncol; 2024 Jun; 46():102018. PubMed ID: 38838436
[TBL] [Abstract][Full Text] [Related]
17. The potential role of RNA N6-methyladenosine in Cancer progression.
Wang T; Kong S; Tao M; Ju S
Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
[TBL] [Abstract][Full Text] [Related]
18. RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.
Wang H; Li C; Wei Q; Zhang E; Yang Y; Sha L; Wang D
Biochem Genet; 2024 Mar; ():. PubMed ID: 38429603
[TBL] [Abstract][Full Text] [Related]
19. WHISTLE: a high-accuracy map of the human N6-methyladenosine (m6A) epitranscriptome predicted using a machine learning approach.
Chen K; Wei Z; Zhang Q; Wu X; Rong R; Lu Z; Su J; de Magalhães JP; Rigden DJ; Meng J
Nucleic Acids Res; 2019 Apr; 47(7):e41. PubMed ID: 30993345
[TBL] [Abstract][Full Text] [Related]
20. Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer.
Ying Y; Wu Y; Zhang F; Tang Y; Yi J; Ma X; Li J; Chen D; Wang X; Liu X; Liu B; Luo J; Zheng X; Xie L
Mol Cancer; 2024 Apr; 23(1):79. PubMed ID: 38658974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
